Sort
15,273 grants matching “antimicrobial resistance”
Cranberry and Prevention of UTI A Comprehensive Approach
$276,134Yale University · R01 · FY2005 · AT
Genetically engineered macrophages to treat pulmonary infections
$276,097Timothy Eoin West · University Of Washington · R21 · FY2020 · AI
SBIR Phase I: Developing NLP-based Platform Technology for Phage-Host Interaction Predictions
$276,000Sofia Sigal-Passeck · Uniphage, Inc. · · FY2022 · TIP
In vivo Models of Defensin Activity
$275,770University Of California Davis · R01 · FY2003 · AI
Modifiable Risk Factors for the Emergence of Resistance to Pseudomonas aeruginosa
$275,758Pranita Tamma · Johns Hopkins University · R21 · FY2021 · AI
Solid-state NMR of antimicrobial and cationic membrane peptides
$275,756Mei Hong · Iowa State University · R01 · FY2010 · GM
Development and Pre-Clinical Testing of Antimicrobial PEKK/Silicon Nitride Trauma Plates with Carbon Fiber Reinforcement
$275,747Ryan Bock · Sintx Technologies, Inc. · R41 · FY2022 · AR
Project 2 Hollow Fiber Project
$275,732George Louis Drusano · University Of Florida · P01 · FY2024 · AI
Rapid Microbial ID Direct From Specimen
$275,712Erik J Nilsson · Pataigin, Llc · R43 · FY2023 · AI
Mechanisms of Macrolide Resistance in Mycobacteria
$275,625Kevin A Nash · Children'S Hospital Of Los Angeles · R01 · FY2009 · AI
Mechanisms of Macrolide Resistance in Mycobacteria
$275,625Kevin A Nash · Children'S Hospital Of Los Angeles · R01 · FY2008 · AI
Structure and Function of Hexapeptide Acyltransferases
$275,447Steven L Roderick · Albert Einstein College Of Medicine · R01 · FY2007 · AI
A GENOMICS APPROACH TO BIOFILMS
$275,391Northeastern University · R01 · FY2004 · GM
Regulation of Salmonella Virulence by the PhoP Protein
$275,279Eduardo A. Groisman · Washington University · R01 · FY2007 · AI
Metagenomic discovery and optimization of novel endolysins targeting Cutibacterium acnes to treat acne vulgaris
$275,250Oliver Wei Liu · Topaz Biosciences, Inc. · R43 · FY2023 · AR
Drs2p Function in Clathrin-coated Vesicle Budding
$275,216Vanderbilt University · R01 · FY2005 · GM
Development of a RIG-I agonist RNA as a cure for chronic Hepatitis B
$275,211Bryan Berube · Hdt Bio Corporation · R43 · FY2023 · AI
Understanding ceftazidime resistance in SHV B-Lactamases
$275,210Robert A. Bonomo · Case Western Reserve University · R01 · FY2007 · AI
Lasso Peptide Discovery
$275,197Aaron James Link · Princeton University · R01 · FY2018 · GM
Innate Immunity in Otitis Media Pathogenesis
$275,001David J. Lim · University Of California Los Angeles · R01 · FY2013 · DC
STTR Phase I: Leveraging Sequencing to Identify and Predict Multidrug Resistance
$275,000Kalen Hall · Informuta, Inc. · · FY2024 · TIP
SBIR Phase I: Automated Gram Stain Interpretation Via Digital Holographic Microscopy
$275,000Kyle Spafford · Macula Vision Systems Inc. · · FY2023 · TIP
SBIR Phase I: Engineering the Plant Microbiome to Reduce Disease in Crops
$274,999Andrea K Wallace · Robigo, Inc. · · FY2023 · TIP
SBIR Phase I: Anti-infective Foley catheters for long-term prevention of catheter-associated urinary tract infections
$274,982Kollbe A Ahn · Acatechol, Inc. · · FY2024 · TIP
SBIR Phase I: Point-of-Care Diagnostic Tool for Identifying Extended Spectrum β-Lactamase E. Coli in Urinary Tract Infection
$274,975Di Kang · Edna Biotech, Inc · · FY2023 · TIP